Listen: A CRISPR milestone, Biogen’s FDA saga, & George Yancopoulos on biotech in 2021
How much can CRISPR really do? Has the FDA been totally honest? And is it OK to mix and match Covid-19 vaccines?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First we talk to George Yancopoulos, head scientist at Regeneron Pharmaceuticals, about the future of CRISPR genome editing and the latest idea for treating obesity. Then, we discuss STAT’s reporting on the cozy relationship between Biogen and the FDA ahead of Aduhelm’s approval and what the ensuing fallout might mean. Before all that, we chat about the latest news in biotech, including vaccine boosters and a decadelong debacle.
